Enter a Ticker Symbol To Get Your Free Bull/Bear Rating & Ranking Report from "Stock Scientist" Mike Turner

Dividend Quote

PANC

Panacos Pharmaceuticals Inc

Add to Scorecard

New Report from the Award-winning Analyst Who Beat the Market Over 15 Years

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.

PANC:Panacos Pharmaceuticals Inc - Stock Quote and Dividend Data

LATEST CLOSE PRICE

< $0.01

EXCHANGE

OTCBB

SECTOR

Health Care

PANC
Panacos Pharmaceuticals Inc Dividend Information
Trailing 12 Month Dividend Yield0.00%
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years

Dividend Payment TypeNone
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone

FREE INVESTOR BRIEFING

Collect an 8% Yield on this "Government Mandated Income Opportunity"

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.
PANC
Panacos Pharmaceuticals Inc Stock Information
Latest Close Price< $0.01
52-Week Low/High$0.00 - $0.00
Percent Held by Institutions0.05%
Revenue$123,000
Net Income$-43,907,000
Cash Flow$-7,799,000
EPS-0.15%
Market Cap$54
PE Ratio0
PE Ratio to Industry66%
Debt-Equity Ratio345.00%
Debt-Equity to Industry1.38%
Total Return Last 12 Months0.00%
Total Return Last 3 Years-99.00%
Total Return Last 5 Years-99.97%
Latest Trade DateJan. 18, 2019
PANC
Panacos Pharmaceuticals Inc Dividend Payment History

No Data available for Payment History.

PANC
Panacos Pharmaceuticals Inc Other Details

Panacos Pharmaceuticals is a development-stage biotechnology company that seeks to develop anti-infective products through the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other major human viral diseases. Co.'s lead product candidate, bevirimat, is a once-daily oral HIV drug candidate in Phase 2 clinical testing. Co. also has research and development programs designed to generate second- and third-generation maturation inhibition products and a research and development program focused on an early step in the HIV virus life cycle, fusion of the HIV virus to human cells.

Web Sitewww.vitechnologies.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Try Dividend Investor PREMIUM for as low as $29

  • Dividend Allstars™ Tool
  • Proprietary Ex-dividend Calendar
  • Dividend Scorecard™ Portfolio Tracker
  • Customized Dividend Stock Screener
  • 4 FREE special reports from leading dividend experts
  • And much more...
 
Panacos Pharmaceuticals Inc Dividend Stock News and Updates

Jan. 16, 2019CLOSE PRICE DECREASE: Panacos Pharmaceuticals Inc (OTCBB: PANC) on 01-16-2019 decreased close price > 10% from $0.00 to $0.00

Read more...

Jan. 12, 2019CLOSE PRICE DECREASE: Panacos Pharmaceuticals Inc (OTCBB: PANC) on 01-12-2019 decreased close price > 10% from $0.00 to $0.00

Read more...

Jan. 05, 2019CLOSE PRICE INCREASE: Panacos Pharmaceuticals Inc (OTCBB: PANC) on 01-05-2019 increased close price > 10% from $0.00 to $0.00

Read more...
More Panacos Pharmaceuticals Inc Dividend News
Biotechnology Dividend Stock News and Updates

Jan. 19, 2019CLOSE PRICE INCREASE: Affymax Inc (OTCBB: AFFY) on 01-19-2019 increased close price > 10% from $0.02 to $0.02

Read more...

Jan. 19, 2019CLOSE PRICE DECREASE: AVAX Technologies, Inc. (OTCBB: AVXT) on 01-19-2019 decreased close price > 10% from $0.00 to $0.00

Read more...

Jan. 19, 2019CLOSE PRICE DECREASE: Eurotech Ltd. (OTCBB: EUOT) on 01-19-2019 decreased close price > 10% from $0.00 to $0.00

Read more...
More Biotechnology Dividend News
X

Search Dividend Investor